Special Issue "Epidemiology of Tobacco and Cannabis Use"

Special Issue Editors

Dr. Heather L. Kimmel
E-Mail Website
Guest Editor
NIDA, NIH, 301 North Stonestreet Ave, Bethesda, MD 20892, USA
Interests: tobacco; marijuana; policy; epidemiology; regulatory science; neuroscience; toxicology
Dr. MeLisa Creamer
E-Mail Website
Guest Editor
NIDA, NIH, 301 North Stonestreet Ave, Bethesda MD 20892, USA
Interests: tobacco; e-cigarettes; epidemiology; adolescent and young adult; surveillance
Dr. Steve Gust
E-Mail Website
Guest Editor
NIDA, NIH, 301 North Stonestreet Ave, Bethesda MD 20892, USA
Interests: cannabis; international

Special Issue Information

Dear Colleagues,

This Special Issue reports on the current epidemiology of tobacco and cannabis use, particularly in the context of the rapidly changing policies regulating these products and the availability of new delivery methods and products on the market. As cannabis policies become more permissive and tobacco policies become more restrictive in the US, the prevalence and patterns of use of these products are shifting. In addition, the introduction of electronic vaping systems has provided alternative delivery systems with yet-to-be understood long-term consequences. Other areas of focus include youth uptake of these substances, use of other substances with tobacco and/or cannabis, and health outcomes associated with tobacco and/or cannabis use. These focus areas are considered in the context of existing mental and physical health conditions, health inequities, and legal environments in the US as well as internationally. Together, this overview will inform prevention and intervention efforts.  

Dr. Heather L. Kimmel
Dr. MeLisa Creamer
Dr. Steve Gust
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Cannabis policy
  • Tobacco policy
  • Domestic and international policy
  • Polysubstance use
  • Health equity
  • Youth substance use

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Association of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3
Int. J. Environ. Res. Public Health 2021, 18(15), 8208; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18158208 - 03 Aug 2021
Viewed by 203
Abstract
The purpose of this study is to evaluate the association of electronic nicotine product (ENP) use and its respiratory manifestations in a nationally representative sample of adolescents in the US. Cross-sectional evidence from 9750 adolescents in wave 3 (October 2015–October 2016) of the [...] Read more.
The purpose of this study is to evaluate the association of electronic nicotine product (ENP) use and its respiratory manifestations in a nationally representative sample of adolescents in the US. Cross-sectional evidence from 9750 adolescents in wave 3 (October 2015–October 2016) of the Population Assessment of Tobacco and Health (PATH) survey was used. Adjusting for demographics, lifetime number of cigarettes and cigars used, home rules about tobacco use, and tobacco used by other household members, we used logistic regression models to examine associations between ENP use and its respiratory manifestations in the past year. Among 9750 adolescents, 12% (n = 1105) used ENP in the past year. Compared to non-users, past-year ENP-users had 37% higher odds of wheezing in general (Adjusted Odds Ratio (AOR) = 1.37, 95% Confidence interval (CI): 1.11–1.71, p = 0.005) and higher odds of wheezing 4–12 times or >12 times per year versus no wheezing (AOR = 1.57, 95% CI: 1.01–2.46, p = 0.05 and AOR = 2.58, 95% CI: 1.04–6.41, p = 0.04, respectively). Additionally, odds of dry cough at night were 23% higher among ENP-users than among non-users (AOR = 1.23, 95% CI: 1.04–1.46, p = 0.02). There was no association between past-year ENP use and exercise-induced wheezing or asthma diagnosis. Among those with asthma, there was no evidence of an association between ENP use and long-acting inhaler or quick-relief inhaler use. ENP use among adolescents is associated with increased frequency of wheezing and dry cough. Early recognition of pulmonary clinical manifestations among young ENP users should be critical considerations in regulatory and prevention efforts to protect public health, and clinical efforts to prevent progression to serious pulmonary complications. Full article
(This article belongs to the Special Issue Epidemiology of Tobacco and Cannabis Use)
Show Figures

Figure 1

Article
Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
Int. J. Environ. Res. Public Health 2021, 18(13), 6719; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18136719 - 22 Jun 2021
Viewed by 493
Abstract
Vaping products containing cannabidiol (CBD), a cannabis-derived compound used in wellness products and available in all 50 US states, were recently implicated in outbreaks of poisonings. Little is known about the commercial availability of CBD products in vape shops (i.e., stores that sell [...] Read more.
Vaping products containing cannabidiol (CBD), a cannabis-derived compound used in wellness products and available in all 50 US states, were recently implicated in outbreaks of poisonings. Little is known about the commercial availability of CBD products in vape shops (i.e., stores that sell e-cigarettes). To document the availability and marketing of CBD products in online vape shops, in June 2020, we used the Google Chrome browser without cached data to collect the first two pages of search results generated by five Google queries (n = 100 search results) indicative of shopping for vaping products (e.g., “order vapes”). We then determined whether and what type of CBD products could be mail-ordered from the returned websites, and whether any explicit health claims were made about CBD. Over a third of the search results (n = 37; 37.0%) directed to vape shops that allowed visitors to also mail-order CBD. These shops sold 12 distinct categories of CBD products–some with direct analogs of tobacco or cannabis products including CBD cigarettes, edibles, flowers, pre-rolled joints, and vapes. Two vape shops made explicit health claims of the therapeutic benefits of CBD use, including in the treatment of anxiety, inflammation, pain, and stress. The abundance and placement of CBD in online vape shops suggests a growing demand and appeal for CBD products among e-cigarette users. Additional surveillance on the epidemiology of CBD use and its co-use with tobacco is warranted. Full article
(This article belongs to the Special Issue Epidemiology of Tobacco and Cannabis Use)
Show Figures

Figure 1

Back to TopTop